SCHEMBL17149188

SCHEMBL17149188

Cc1cc(C(C)C)c2ccccc2c1OC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.39
▸ MAPT P10636 4/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ GAA P10253 2/20 0.36
▸ TP53 P04637 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ LMNA P02545 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ PLA2G1B P04054 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ ATG4B Q9Y4P1 1/20 0.33
▸ GABRA1 P14867 3/20 0.33
▸ GABRB2 P47870 2/20 0.33
▸ GABRB1 P18505 2/20 0.33
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612308 0.84 HTT (0.47) HTTMAPTKDM4EGAATP53
SCHEMBL24414088 0.78 LDHA (0.33) HTTABCB1
SCHEMBL30503962 0.77 KDM4E (0.39) HTTMAPTKDM4EGAATP53
SCHEMBL29366786 0.76 SMN1; SMN2 (0.50) MAPTKDM4EHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL15512745 0.76 SMN1; SMN2 (0.50) MAPTKDM4EHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL24413826 0.76 ALDH1A1 (0.45) MAPTKDM4EALDH1A1GABRA1GABRB1
SCHEMBL31460703 0.75 CYP1A2 (0.40) HTTMAPTGAALMNAALDH1A1
SCHEMBL23271933 0.74 ALDH1A1 (0.44) MAPTKDM4EHSD17B10SMN1; SMN2ALDH1A1
SCHEMBL19612509 0.73 CYP1A2 (0.42) MAPTKDM4EGAAHSD17B10SMN1; SMN2
SCHEMBL754409 0.72 MAPK1 (0.42) MAPTKDM4EHSD17B10SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220143183-A1 PHOTOSWITCHABLE PROTACS AND SYNTHESIS AND USES THEREOF NEW YORK UNIVERSITY 2022-05-12 — — US disclosed
US-9815997-B2 Organic electroluminescence device and ink composition IDEMITSU KOSAN CO., LTD. (JP) 2017-11-14 — — US disclosed
US-20150284580-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND INK COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2015-10-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220143183-A1 PHOTOSWITCHABLE PROTACS AND SYNTHESIS AND USES THEREOF MDM2, UBE3C, CUL1 HTT 792/4885MAPT 1788/4885KDM4E 1635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback